Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001204.7(BMPR2):c.529+2T>C

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA350338507

425800 (ClinVar)

Gene: BMPR2

Condition: pulmonary arterial hypertension

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: 26778d12-b52a-42a4-9b61-c6e1048a2505

Approved on: 2024-05-03

Published on: 2024-05-03

HGVS expressions

NM_001204.7:c.529+2T>C

NM_001204.7(BMPR2):c.529+2T>C

NC_000002.12:g.202513831T>C

CM000664.2:g.202513831T>C

NC_000002.11:g.203378554T>C

CM000664.1:g.203378554T>C

NC_000002.10:g.203086799T>C

NG_009363.1:g.142505T>C

ENST00000374580.10:c.529+2T>C

ENST00000638587.1:c.460+2T>C

ENST00000374574.2:c.529+2T>C

ENST00000374580.8:c.529+2T>C

NM_001204.6:c.529+2T>C

Uncertain Significance

PVS1_Strong PM2_Supporting

PM4 PP3

Evidence Links 0

Expert Panel

Pulmonary Hypertension VCEP

Criteria Specification Information

Criteria Specification: ClinGen Pulmonary Hypertension Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for BMPR2 Version 1.1.0

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Pulmonary Hypertension VCEP

The NM_001204.7(BMPR2) c.529+2T>C variant is located in the canonical donor splice site of intron 4. It is predicted to cause skipping of biologically relevant exon 4 (111 bp), resulting in an in-frame deletion of amino acids Ser140-Thr176 within the transmembrane domain, that is predicted to escape nonsense-mediated decay (PVS1_strong). The predictions were recorded under PVS1, so PP3 was not applied to avoid double counting. Although the variant is predicted to cause a change in the length of the protein due to in-frame deletion, no functional data are available and thus PM4 was not applied. This variant is absent from gnomAD v2.1.1 and v3.1.2 (PM2_supporting). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PVS1_strong, PM2_supporting. (VCEP specifications version 1.1, 1/18/2024)

PVS1_Strong

The variant (NM_001204.7 (BMPR2): c.529+2T>C) occurs within the canonical splice donor site (+2) of intron 4. Splice AI predicts loss of donor splice site (score 0.97) that may lead to skipping of biologically relevant exon 4 (111bp), resulting in an in-frame deletion of 37 amino acids (140-176) present in the transmembrane domain. No experimental data are available for this variant.

PM2_Supporting

This variant is absent from gnomAD controls (v2.1.1 and v3.1.2)

PM4

The variant (NM_001204.7: c.529+2T>C) is predicted to cause a change in the length of the protein due to in-frame deletion of 37 amino acids (140-176). However, no functional data are available to support this prediction, which has been scored under PVS1.

PP3

The computational splicing predictor Splice AI gives a score of (0.97) for donor splice site loss, predicting that the variant disrupts the donor splice site of intron 4 of BMPR2. However, the predictions were recorded under PVS1 so PP3 was not applied to avoid double counting.

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.